Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
France Bed Holdings Co., Ltd. (7840.T)
Tokyo, JP
France Bed Holdings Co.,Ltd., through its subsidiaries, engages in the medical services and home furnishing and health businesses in Japan. It operates through the Medical Services Business and Home Furnishings and Health Business segments. The company is involved in the development and proposal of products for facilities, such as monitoring and nursing care robots; and manufacture, purchase, rental, retail, and wholesale of nursing care products and welfare equipment such as multi-fit beds, handrails, and multi-position beds, as well as health support products. It also offers linen supply for medical and welfare facilities and hotels; consultations, including nursing care consultations and care plan creation; and electrical stimulation rehabilitation equipment that can be used at home and in medical settings. In addition, the company engages in the operation of showrooms and PR studios; provision of sofas, sofa beds, and bed-type massagers; exhibition sales of furniture, and fashion and jewelry; in-home long-term care support business, long-term care business for residents of specified facilities, dementia-friendly communal living long-term care, small-scale multifunctional in-home care, outpatient care, rental housing for the elderly; and design and construction of guest rooms and lobbies, as well as interior coordination. It offers its products through a range of sales channels, including furniture stores, department stores, interior shops, and hotels. France Bed Holdings Co.,Ltd. was incorporated in 2004 and is based in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.93% | +1.11% | -4.28% | -4.07% | -3.48% | -3.27% | +1.11% | +11.95% | +36.40% | +31.20% | -52.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Specialties: +8.3%+2.0% Q1'26: +3.5% (vs Q1'25)
-
EPS growth Medical - Specialties: +10.1%-4.4% Q1'26: +7.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%+3.7% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Specialties: +12.6%+7.0% Q1'26: +7.4% (vs Q1'25)
-
ROIC Medical - Specialties: +6.6%+6.6% ★ Q1'26: +8.6% (vs Q1'25)
-
Share dilution Medical - Specialties: 0.0%-2.5% ★ Q1'26: -4.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×1.79× Q1'26: 1.66× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2018 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
|---|---|---|---|---|---|---|---|
| Revenue |
51.91B
est: 52.60B (-1.3%)
|
52.64B
est: 52.90B (-0.5%)
|
52.41B
est: 53.00B (-1.1%)
|
52.43B
est: 51.70B (+1.4%)
|
54.40B
est: 53.99B (+0.8%)
|
58.58B
est: 55.90B (+4.8%)
|
59.15B
est: 57.80B (+2.3%)
|
| EBITDA |
5.36B
est: 8.98B (-40.3%)
|
6.21B
est: 9.03B (-31.3%)
|
6.49B
est: 9.05B (-28.2%)
|
8.53B
est: 8.82B (-3.4%)
|
9.49B
est: 9.22B (+3.0%)
|
10.28B
est: 9.54B (+7.7%)
|
10.39B
est: 9.73B (+6.8%)
|
| EBIT |
1.73B
est: 3.94B (-56.3%)
|
2.60B
est: 3.97B (-34.5%)
|
2.86B
est: 3.97B (-28.1%)
|
3.59B
est: 3.88B (-7.3%)
|
3.96B
est: 4.05B (-2.2%)
|
4.46B
est: 4.19B (+6.3%)
|
4.79B
est: 5.24B (-8.5%)
|
| Net Income |
904.00M
est: 1.43B (-36.9%)
|
1.40B
est: 1.51B (-7.2%)
|
1.81B
est: 1.71B (+5.4%)
|
2.30B
|
2.56B
est: 2.51B (+2.1%)
|
2.70B
est: 2.73B (-0.9%)
|
3.13B
est: 3.06B (+2.4%)
|
| SGA |
22.29B
est: 24.20B (-7.9%)
|
22.10B
est: 24.34B (-9.2%)
|
22.83B
est: 24.39B (-6.4%)
|
23.79B
est: 23.79B (+0.0%)
|
25.08B
est: 24.84B (+1.0%)
|
26.71B
est: 25.72B (+3.9%)
|
27.30B
est: 26.60B (+2.7%)
|
| EPS |
21.12
est: 37.50 (-43.7%)
|
33.43
est: 39.50 (-15.4%)
|
44.88
est: 44.80 (+0.2%)
|
59.86
|
69.35
est: 65.53 (+5.8%)
|
74.80
est: 71.29 (+4.9%)
|
87.28
est: 80.06 (+9.0%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.04% | 169.6K | 0.58% |
| 2 | WisdomTree International SmallCap Dividend Fund DLS | 0.02% | 228.5K | 0.58% |
| 3 | WisdomTree International Equity Fund DWM | 0.01% | 70.5K | 0.48% |
| 4 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.01% | 31.8K | 0.48% |
| 5 | Schwab International Small-Cap Equity ETF SCHC | 0.01% | 369.9K | 0.06% |
| 6 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 603.1K | 0.06% |
| 7 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 30.0K | 0.45% |
| 8 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.00% | 39.2K | 0.39% |
| 9 | Dimensional - International Small Cap ETF DFIS | 0.00% | 196.3K | 0.39% |
| 10 | iShares Core TOPIX ETF 1475.T | 0.00% | 533.1K | 0.05% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kazumi Ikeda | Executive Vice President & Representative Director | — | male |
| Masaaki Ohyama | Executive Officer | — | — |
| Shigeru Ikeda | Chairman, President & Chief Executive Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7840.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
